Table 1. Distribution of cells in cell cycle.
Type of treatment | Days after treatment | %Sub-G1 | %G1 | %S | %G2/M | %Polyploidy |
---|---|---|---|---|---|---|
Mock | 1 | 1.63 | 49.15 | 9.68 | 22.35 | 16.3 |
3 | 2.32 | 61.95 | 6.01 | 20.1 | 8.98 | |
5 | 4.2 | 63.2 | 5.05 | 13.65 | 13.25 | |
10 | 1.68 | 66.6 | 4.51 | 15.5 | 9.89 | |
TMZ | 1 | 3.26 | 47.95 | 11.55 | 22.6 | 14.55 |
3 | 1.4 | 20.1 | 12.6 | 50.7 | 14.15 | |
5 | 1.63 | 6 | 4.27 | 61.15 | 27.85 | |
10 | 1.18 | 9.2 | 6.19 | 50.1 | 32.4 | |
CRAd-S-pk7 | 1 | 2.07 | 49 | 12.45 | 22.65 | 14.5 |
3 | 3.57 | 65.55 | 7.36 | 17.6 | 6.62 | |
5 | 4.58 | 60.3 | 3.3 | 15.8 | 13.35 | |
10 | 4.12 | 23.45 | 15.3 | 23.85 | 30.85 | |
Combination | 1 | 2.92 | 45.6 | 11.45 | 24.1 | 16.35 |
3 | 2.21 | 33.5 | 10.6 | 39.7 | 12.3 | |
5 | 3.31 | 9.065 | 6.1 | 53.9 | 29.45 | |
10 | 2.35 | 11.65 | 7.2 | 38.4 | 40.5 |
Abbreviation: TMZ=temozolomide.